ClinicalTrials.gg
CompletedNCT03935542Updated May 2, 2019

Assessment of Diagonal Branch Territory

An observational study in Stable Angina and Unstable Angina, sponsored by Bon-Kwon Koo. Completed at 1 site in Korea, Republic of. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2019-05-02.

Sponsored by Bon-Kwon Koo · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
355
Ages
20 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 30 studies in Angina, Stable with a site in Korea, Republic of — 1 open to participants now, 5 under way, none of them phase 3. Angina, Stable · Korea, Republic of.

Started
2015
with 2 others
Observational
6 of 30
none open now
Registered
28th of 30
by date
Lead sponsor
1 of 30
Bon-Kwon Koo

Among the 30 studies in Angina, Stable with a site in Korea, Republic of, this one is one of 3 that started in 2015, is one of 6 observational ones, and was the 28th registered.

Angina, Stable

344 studies on the registry are indexed under Angina, Stable; 56 are open to participants now.

Browse Angina, Stable studies →

Open to participants now

1 of the 30 studies in Angina, Stable with a site in Korea, Republic of is open now. Recruiting first, the newest first:

A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →

Who these studies take

Of the 38 Angina, Stable studies recruiting now, 32 (84%) set no upper age limit and 2 (5%) stop at 75 or younger; 2 take children under 18; 1 takes healthy volunteers.

This study: 20 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 30 studies in Angina, Stable with a site in Korea, Republic of, or all of them as a file.
02

Study summary

This study was performed to investigate the anatomical attributes that determine myocardial territory of diagonal branches and to develop a prediction model for clinically relevant branches using myocardial perfusion imaging (MPI) and coronary CT angiography (CCTA).

Read the detailed description

Bifurcation lesion is one of the most challenging lesion subsets in the field of percutaneous coronary intervention (PCI). Despite the recent advances in PCI techniques and stent technology, most randomized studies failed to prove the superiority of systematic 2 stenting strategy compared with provisional side branch intervention strategy.

A certain amount of ischemic burden is required to achieve the benefit of revascularization over medical treatment. Compared with major epicardial vessels, side branches are smaller, more variable in anatomy, supplying less myocardium and less clinically relevant. Therefore, it is important to assess the myocardial mass at risk of side branches to determine the appropriate treatment strategy for bifurcation lesions. However, how to define the clinically relevant side branches which can be associated with the benefit of revascularization in a cardiac catheterization laboratory is not well-known.

The investigators performed this study to investigate the anatomical attributes that determine ischemic burden and myocardial territory of diagonal branches and to develop a prediction model for a clinically relevant diagonal branch using myocardial perfusion imaging (MPI) and coronary CT angiography (CCTA).

03

Conditions studied

  • Stable Angina
  • Unstable Angina

Keywords

  • Bifurcation
  • Side branch
  • Ischemia
  • Myocardium
  • Revascularization
04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with angina pectoris

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with severe jailed diagonal branch disease with available MPI in 3 months (MPI arm)
  • Patients who had available FMM value of diagonal branches from a previous multicenter prospective CCTA registry (CCTA arm)

Exclusion criteria

Exclusion Criteria:

  • Patients with >50% stenosis at left anterior descending coronary artery (LAD) or left circumflex artery (LCx), regional wall motion abnormality at LAD territory (MPI arm)
  • Patients with diffuse diagonal branch disease (CCTA arm)
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
355 participants (actual)
Patient registry
No

Groups and cohorts

  • MPI arm

    For the MPI arm, patients with severe jailed diagonal branch disease with available MPI in 3 months were selected from the Seoul National University Hospital Cardiac Catheterization and MPI database.

  • CCTA arm

    For the CCTA arm, patients from a previous multicenter prospective CCTA registry were retrospectively reviewed for a post-hoc analysis.

06

What researchers measure

Primary outcomes

  1. Angiographic attributes for diagonal branches

    Angiographic attributes for diagonal branches were visually defined as follows : 1. Size was a binary attribute of vessel diameter ≥ 2.5mm or \< 2.5mm. 2. Number was counted as one, two, and 3 or more diagonal branches. 3. Dominancy in patients with 2 diagonal branches (D1/2 dominancy) was a binary attribute for one of two diagonal branches whose diameter was more than two times larger than its smaller counterpart. 4. LCx dominancy was defined as a left-dominant system or a presence of obtuse marginal branch originating within proximal 1/3 of LCx and crossing LAD at right anterior oblique caudal view.

    Time frame: through study completion, an average of 1year

  2. Sensitivity of prediction model

    Prediction model using anatomical attributes to define clinical relevance of diagonal branches will be developed.

    Time frame: through study completion, an average of 1year

  3. Specificity of prediction model

    Prediction model using anatomical attributes to define clinical relevance of diagonal branches will be developed.

    Time frame: through study completion, an average of 1year

  4. Negative predictive value of prediction model

    Prediction model using anatomical attributes to define clinical relevance of diagonal branches will be developed.

    Time frame: through study completion, an average of 1year

  5. Positive predictive value of prediction model

    Prediction model using anatomical attributes to define clinical relevance of diagonal branches will be developed.

    Time frame: through study completion, an average of 1year

  6. Area under the curve of prediction model

    Prediction model using anatomical attributes to define clinical relevance of diagonal branches will be developed.

    Time frame: through study completion, an average of 1year

  7. Accuracy of prediction model

    Prediction model using anatomical attributes to define clinical relevance of diagonal branches will be developed.

    Time frame: through study completion, an average of 1year

Secondary outcomes

  1. %Ischemia

    Myocardium of perfusion image was divided into 20 segments, and summed rest score (SRS), summed stress score (SSS), and summed difference score (SDS) were scored in each segment according to a 5-grade system (0-4) for the assessment of perfusion status. (1) SSS and SDS of diagonal segments were converted to percent of myocardial ischemia (%ischemia) of diagonal territory by dividing summed scores by 80 and multiplying by 100.

    Time frame: through study completion, an average of 1year

  2. %FMM

    FMM was calculated using stem-and-crown model as described in the parent study. (2) FMM of each diagonal brach was converted to percent FMM (%FMM) of diagonal branch by dividing each FMM by left ventricular myocardial mass.

    Time frame: through study completion, an average of 1year

07

Study locations

1 site
  • Seoul National University Hospital
    Seoul, Korea, Republic of
08

References and documents

Publications

  • Paeng JC, Lee DS, Cheon GJ, Lee MM, Chung JK, Lee MC. Reproducibility of an automatic quantitation of regional myocardial wall motion and systolic thickening on gated 99mTc-sestamibi myocardial SPECT. J Nucl Med. 2001 May;42(5):695-700. PubMed 11337562 ↗
  • Kim HY, Lim HS, Doh JH, Nam CW, Shin ES, Koo BK, Yoon MH, Tahk SJ, Kang DK, Song YB, Hahn JY, Choi SH, Gwon HC, Lee SH, Kim EK, Kim SM, Choe Y, Choi JH. Physiological Severity of Coronary Artery Stenosis Depends on the Amount of Myocardial Mass Subtended by the Coronary Artery. JACC Cardiovasc Interv. 2016 Aug 8;9(15):1548-60. doi: 10.1016/j.jcin.2016.04.008. Epub 2016 Jul 13. PubMed 27423225 ↗
  • Jeon WK, Park J, Koo BK, Suh M, Yang S, Kim HY, Lee JM, Kim KJ, Choi JH, Lim HS, Paeng JC, Hwang D, Kim HS; Collaborators. Anatomical attributes of clinically relevant diagonal branches in patients with left anterior descending coronary artery bifurcation lesions. EuroIntervention. 2020 Oct 9;16(9):e715-e723. doi: 10.4244/EIJ-D-19-00534. PubMed 31719001 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Aug 2015 to primary completion in Feb 2017, 18 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 26, 2019
First posted
May 2, 2019
StartActual
Aug 3, 2015
Primary completionActual
Feb 6, 2017
CompletionActual
Oct 8, 2018
Last update
May 2, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 2, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03935542
Lead sponsor
Bon-Kwon Koo
Collaborators
Seoul National University Hospital, Naju National Hospital, Chonnam National University Hospital, Samsung Medical Center, Ewha Womans University, Ajou University School of Medicine
Responsible party
Bon-Kwon Koo (Professor, Seoul National University Hospital) — Sponsor-investigator
First posted
May 2, 2019
Start date
Aug 3, 2015
Primary completion
Feb 6, 2017
Completion
Oct 8, 2018
Last update
May 2, 2019

Study contacts

Bon-Kwon Koo, MD, PhD
principal investigator · Seoul National University Hospital
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion